Research shows limited impact of ban on flavored e-cigarettes

Dec.01.2022
Research shows limited impact of ban on flavored e-cigarettes
The US ban on flavored e-cigarettes has had limited effectiveness, as users turn to alternative products and flavors.

On February 6, 2020, the United States Food and Drug Administration banned the sale of several flavors of electronic cigarettes, with some significant exceptions.


According to a survey published in the journal "Tobacco Control," out of 3500 adult users of electronic cigarettes who were surveyed, less than 5% of them stopped using electronic cigarettes due to the ban on flavored e-cigarettes. The remaining respondents switched to other types or flavors of electronic cigarettes or other tobacco products that were not covered by the ban.


More and more literature suggests that the flavorings in e-cigarettes can cause harm when inhaled, making a ban on these flavorings reasonable, according to tobacco research expert and Professor of Public Health Sciences and Community Center Deborah J. Ossip. "But bans don't seem to be effective. People, including young people, can still access flavored products and are still using them," she added. This statement was made at the University of Rochester Medical Center's Department of Public Health and Prevention.


According to Dongmei Li, the lead author of the study and associate professor of clinical and translational research, obstetrics and gynecology, and public health sciences, a significant part of the problem is that the ban does not cover newer products such as disposable e-cigarette pods and e-cigarette pods that use canisters instead of cartridges/boxes.


Other forms of flavored electronic cigarettes, particularly disposable ones, have become very popular after FDA policies were implemented," said Li. "The FDA's policies did not prohibit products with mint or tobacco flavors - our research indicates that many people switched to mint-flavored e-cigarettes after the ban. It seems that many people find menthol to be a favorable taste.


According to this study, nearly 30% of the survey respondents switched to canned or disposable flavored e-cigarettes, and another 30% switched to mint or tobacco flavored pods. Some reported turning to traditional tobacco products: 14% switched to combustible products like cigarettes, and 5% switched to smokeless products such as chewing or dipping tobacco. Less than 5% of respondents stopped using e-cigarettes after the FDA ban.


Researchers used statistical models to identify factors related to changes in e-cigarette usage behavior. They found a close correlation between using tank system e-cigarettes and switching to other flavors not regulated by the FDA's flavor law enforcement policies.


The use of mint-flavored electronic cigarettes over the past 30 days is associated with switching to mint-flavored electronic cigarettes. Those who reported smoking every day or every few days were more likely to switch to tobacco-flavored electronic cigarettes or combustible tobacco products.


On the other hand, people who use flavored electronic cigarettes without nicotine are more likely to quit smoking. Although the study was not intended to establish a causal relationship, the association supports previous research showing that reducing nicotine levels in cigarettes can help smokers quit. However, further research is needed to better understand the relationship between the use of low-nicotine electronic cigarettes and smoking cessation.


Looking towards the future, Li Dongmei believes that if this policy covers all flavors of electronic cigarettes (including mint and all types of electronic cigarettes) and actively monitors the implementation and compliance of the policy, then the policy may be effective. "Both are important in reducing the popularity of electronic cigarettes among young people in the United States," she said.


2FIRSTS will continue to cover this topic, with updates available on the "2FIRSTS APP". Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
The Philippines’ Bureau of Internal Revenue is intensifying enforcement against illicit vape and tobacco products ahead of the Christmas shopping season, directing regional and enforcement offices to strengthen monitoring of production sites, warehouses, distribution channels and retail outlets. The BIR destroyed 240,550 illicit vape products in August with an estimated tax liability of about PHP1.53 billion. A nationwide tax-compliance operation in July also inspected 3,590 businesses involved in tobacco and vapor products.
Regulations
Sep.17 by 2Firsts Perspectives
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03